These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 13153700)
21. Clinical use of phenylbutazone, a potent anti-rheumatic agent; report of its effectiveness in four cases. PIERIK MG R I Med J; 1953 Apr; 36(4):196-7. PubMed ID: 13048452 [No Abstract] [Full Text] [Related]
22. [Experience in treatment of the so-called non-specific infectious arthritis (rheumatoid arthritis) with butadione]. MAKARENKO II Sov Med; 1955 Jul; 19(7):44-8. PubMed ID: 13256091 [No Abstract] [Full Text] [Related]
23. [Results of phenylbutazone therapy of arthritic diseases]. PARRINI L Minerva Ortop; 1955 Feb; 6(2):69-71. PubMed ID: 14383573 [No Abstract] [Full Text] [Related]
24. Observations on the use of butazolidin in arthritis. DAVIES HR; BARTER RW; GEE A; HIRSON C Br Med J; 1952 Dec; 2(4799):1392-4. PubMed ID: 12997794 [No Abstract] [Full Text] [Related]
25. [Treatment of rheumatic arthritis and gout with phenylbutazone]. PLICHET A Presse Med (1893); 1952 Sep; 60(58):1217-8. PubMed ID: 13026950 [No Abstract] [Full Text] [Related]
26. [Therapy of arthrosis deformans with butazolidin]. NATTERER G; SCHAAL K Dtsch Med Wochenschr; 1953 Aug; 78(33-34):1100-2. PubMed ID: 13083194 [No Abstract] [Full Text] [Related]
27. [Irgapyrin and phenylbutazone in rheumatic diseases]. MESSIAS AR; MESSIAS SR; FROES Hde S Rev Bras Med; 1955 Jan; 12(1):9-16. PubMed ID: 14372289 [No Abstract] [Full Text] [Related]
28. [Indication and certain methods of application of phenylbutazone, butazolidine, with special reference to rheumatic disease]. RATTI G; PASARGIKLIAN E; BALLABIO CB Reumatismo; 1953; 5(4):231-41. PubMed ID: 13121371 [No Abstract] [Full Text] [Related]
29. Phenylbutazone toxicity; report of two cases. BECKER IM; SHEA MC U S Armed Forces Med J; 1954 Feb; 5(2):259-65. PubMed ID: 13122927 [No Abstract] [Full Text] [Related]
30. [Phenylbutazone therapy of arthroses and lumbosciatica due to hernia of intervertebral disk]. BRUNELLI G Minerva Med; 1954 Jun; 45(50):1819-23. PubMed ID: 13193749 [No Abstract] [Full Text] [Related]
31. [Further tests of phenylbutazone; experimental study of its elimination in urine and organic fluids and behavior of the uropepsin test]. LUCHERINI T; NATALE P; CONESTABILE E; CERIMELE E Reumatismo; 1953; 5(5):303-12. PubMed ID: 13167522 [No Abstract] [Full Text] [Related]
32. [Rheumatoid arthritis]. DAVIS E Harefuah; 1954 Feb; 46(4):80-1. PubMed ID: 13162321 [No Abstract] [Full Text] [Related]
33. The management of rheumatoid arthritis. KELLY M Med Illus; 1955 May; 9(5):302-10. PubMed ID: 14369441 [No Abstract] [Full Text] [Related]
36. Agranulocytosis following phenylbutazone (Butazolidin). BRANDWEIN S N Y State J Med; 1953 Jul; 53(13):1577-8. PubMed ID: 13072836 [No Abstract] [Full Text] [Related]
37. [Butazolidine therapy of rheumatoid arthritis and Bechterew's disease]. MEYER MP Ned Tijdschr Geneeskd; 1955 May; 99(22):1546-53. PubMed ID: 14394243 [No Abstract] [Full Text] [Related]
38. [Digestive complications of phenylbutazone]. PERLES L; ZARA M; CHIMENES H Rev Rhum Mal Osteoartic; 1953 May; 20(5):419-21. PubMed ID: 13101352 [No Abstract] [Full Text] [Related]
39. Multiple toxic effects of phenylbutazone; report of a fatal case. FRASER TN Br Med J; 1955 May; 1(4925):1318-20. PubMed ID: 14363877 [No Abstract] [Full Text] [Related]